NCT01820637

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project With Boston Scientific's Innova Drug Eluting Stent

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 57 (actual)
• Sponsor: Boston Scientific Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To determine whether the Boston Scientific nitinol drug-eluting stent shows acceptable performance at 9 months when treating Superficial Femoral (SFA) and/or Proximal Popliteal Artery (PPA) lesions.

Conditions

• Atherosclerosis of Native Arteries of the Extremities

Interventions

Type	Name	Description
DEVICE	The Boston Scientific DES SFA Paclitaxel-Eluting Self-Expanding Stent System (DES SFA)	Drug-eluting SFA self-expanding stent

Timeline

• Start date: 2013-08-23
• Primary completion: 2014-12-01
• Completion: 2017-02-20
• First posted: 2013-03-29
• Last updated: 2019-03-22
• Results posted: 2019-03-22

Locations

13 sites across 5 countries: Australia, Austria, Belgium, Germany, New Zealand